- Funding
- $5M (Oct 2026)
MintNeuro is an Imperial College London spin-out that designs chips for neural devices: they sense nerve signals, process them and deliver stimulation. Implant makers use them instead of adapting generic parts or designing their own silicon.
It has a multi-year supply deal with Motif Neurotech, whose implant targets treatment-resistant depression, and is integrating with Amber Therapeutics. In October 2026 it raised $5 million led by Odyssey Ventures to scale commercially and grow in the US.